BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 30827126)

  • 1. Biologics for chronic inflammatory skin diseases: an update for the clinician.
    Yao Y; Ravn Jørgensen AH; Thomsen SF
    J Dermatolog Treat; 2020 Mar; 31(2):108-130. PubMed ID: 30827126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Navigating Targeted Therapeutics in Dermatology: Biologics and Small Molecules.
    Costello C; Maarouf M; Shi V
    J Drugs Dermatol; 2018 Dec; 17(12):1330-1332. PubMed ID: 30586268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-psoriatic dermatologic uses of monoclonal antibody therapy.
    Sockolov ME; Alikhan A; Zargari O
    J Dermatolog Treat; 2009; 20(6):319-27. PubMed ID: 19954387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
    Kaufman BP; Alexis AF
    Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Practical Guide to Using Biologics in Pediatric Dermatology.
    George A; Lansang RP; Lansang P; Gooderham M
    J Cutan Med Surg; 2024; 28(1):59-67. PubMed ID: 38229411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics in patients with skin diseases.
    Veilleux MS; Shear NH
    J Allergy Clin Immunol; 2017 May; 139(5):1423-1430. PubMed ID: 28477721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Biologics During the COVID-19 Pandemic.
    Jones ME; Kohn AH; Pourali SP; Rajkumar JR; Gutierrez Y; Yim RM; Armstrong AW
    Dermatol Clin; 2021 Oct; 39(4):545-553. PubMed ID: 34556244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What's New in Dermatological Therapy?].
    Bachelez H
    Ann Dermatol Venereol; 2015 Dec; 142 Suppl 3():S49-54. PubMed ID: 26792414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in biologic and small molecule therapies for hidradenitis suppurativa.
    Chen SX; Greif C; Gibson RS; Porter ML; Kimball AB
    Expert Opin Pharmacother; 2022 Jun; 23(8):959-978. PubMed ID: 35470765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Latest Drugs and Small Molecule Inhibitors for Skin and Hair.
    Kalhan V; Sadick N
    J Drugs Dermatol; 2017 Dec; 16(12):1224-1228. PubMed ID: 29240857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics for hidradenitis suppurativa: an update.
    Włodarek K; Ponikowska M; Matusiak Ł; Szepietowski JC
    Immunotherapy; 2019 Jan; 11(1):45-59. PubMed ID: 30702012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa.
    Porter ML; Golbari NM; Lockwood SJ; Kimball AB
    Semin Cutan Med Surg; 2018 Sep; 37(3):182-189. PubMed ID: 30215636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa.
    Aarts P; Dudink K; Vossen ARJV; van Straalen KR; Ardon CB; Prens EP; van der Zee HH
    Drugs; 2021 Aug; 81(12):1397-1410. PubMed ID: 34283386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Psoriasis: Novel Uses for Biologic Response Modifiers in Pediatric Dermatology.
    Bellodi-Schmidt F; Shah KN
    Pediatr Dermatol; 2016; 33(1):18-27. PubMed ID: 26607958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile.
    Ganzetti G; Campanati A; Molinelli E; Offidani A
    Curr Drug Saf; 2016; 11(1):12-21. PubMed ID: 26463243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological Therapies for Atopic Dermatitis: A Systematic Review.
    Zhou S; Qi F; Gong Y; Zhang J; Zhu B
    Dermatology; 2021; 237(4):542-552. PubMed ID: 33735876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What’s news in dermatological therapy?].
    Guillot B
    Ann Dermatol Venereol; 2013 Nov; 140 Suppl 3():S293-302. PubMed ID: 24365501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.
    Trent JT; Kerdel FA
    Dermatol Nurs; 2005 Apr; 17(2):97-107. PubMed ID: 15916184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label uses of TNF-a inhibitors and IL-12/23 inhibitors in dermatology.
    Hong JJ; Hadeler EK; Mosca ML; Brownstone ND; Bhutani T; Liao WJ
    Dermatol Online J; 2021 Nov; 27(11):. PubMed ID: 35130397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.
    Mansilla-Polo M; Escutia-Muñoz B; Botella-Estrada R
    Actas Dermosifiliogr; 2023 Oct; 114(9):T772-T783. PubMed ID: 37541580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.